# Inducing Immune Quiescence the Genital Tract With ASA

> **NCT03629327** · NA · UNKNOWN · sponsor: **University of Manitoba** · enrollment: 300 (estimated)

## Conditions studied

- HIV

## Interventions

- **DRUG:** ASA 81mg
- **OTHER:** Control Group
- **DRUG:** ASA 325mg

## Key facts

- **NCT ID:** NCT03629327
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-10
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03629327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03629327, "Inducing Immune Quiescence the Genital Tract With ASA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03629327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*